Queen Sirikit National Institute of Child Health

posted Aug 11, 2009, 6:41 AM by Surakameth Mahasirimongkol   [ updated Aug 11, 2009, 5:37 PM ]
The meeting with Clinical Neurologist and Dermatologists in the Queen Sirikit National Institute of Child Health on 11/8/2009 was concluded that the following three activities shall be set up for the pharmacogenomics research collaboration between DMSc and the QSNICH.

1) Case-control study for association analysis of HLA-B*1502 in Thai Children who prescribed Carbamazepine.
2) Participating in the multi-center clinical research network for clinical investigation of SJS/TENS in Thailand.
3) Operational study for Prospective intervention using HLA-B*1502 status to prevent Carbamazepine induced SJS/TENS.